Concepts (81)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Treatment Refusal | 2 | 2015 | 23 | 0.890 |
Why?
|
| Prostate-Specific Antigen | 1 | 2023 | 145 | 0.740 |
Why?
|
| Colorectal Neoplasms | 4 | 2023 | 502 | 0.690 |
Why?
|
| Hospitals, General | 1 | 2015 | 5 | 0.490 |
Why?
|
| Insurance Coverage | 1 | 2015 | 108 | 0.460 |
Why?
|
| Thiocarbamates | 1 | 2014 | 5 | 0.440 |
Why?
|
| Androstadienes | 1 | 2014 | 19 | 0.440 |
Why?
|
| Length of Stay | 1 | 2015 | 231 | 0.430 |
Why?
|
| Disease-Free Survival | 1 | 2014 | 116 | 0.430 |
Why?
|
| Prostatic Neoplasms | 1 | 2023 | 1068 | 0.410 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2015 | 209 | 0.410 |
Why?
|
| Patient Dropouts | 1 | 2013 | 31 | 0.390 |
Why?
|
| Health Services Accessibility | 1 | 2015 | 680 | 0.330 |
Why?
|
| Breast Neoplasms | 5 | 2022 | 1679 | 0.310 |
Why?
|
| Mental Disorders | 1 | 2013 | 377 | 0.290 |
Why?
|
| Early Detection of Cancer | 4 | 2023 | 428 | 0.250 |
Why?
|
| United States | 7 | 2024 | 5072 | 0.240 |
Why?
|
| Substance-Related Disorders | 1 | 2013 | 825 | 0.230 |
Why?
|
| Mass Screening | 3 | 2023 | 531 | 0.220 |
Why?
|
| Health Care Surveys | 2 | 2015 | 152 | 0.210 |
Why?
|
| Mastectomy, Segmental | 3 | 2022 | 25 | 0.210 |
Why?
|
| Aged, 80 and over | 5 | 2018 | 2803 | 0.210 |
Why?
|
| Patient Discharge | 2 | 2015 | 131 | 0.210 |
Why?
|
| Aged | 7 | 2022 | 7982 | 0.200 |
Why?
|
| Treatment Outcome | 3 | 2018 | 1586 | 0.190 |
Why?
|
| Health Policy | 1 | 2024 | 184 | 0.190 |
Why?
|
| Humans | 14 | 2024 | 42163 | 0.190 |
Why?
|
| Communication | 1 | 2023 | 207 | 0.170 |
Why?
|
| Sex Factors | 2 | 2015 | 1008 | 0.170 |
Why?
|
| Decision Making | 1 | 2023 | 242 | 0.170 |
Why?
|
| Mental Health | 1 | 2024 | 363 | 0.160 |
Why?
|
| Young Adult | 3 | 2015 | 4936 | 0.160 |
Why?
|
| Adolescent | 3 | 2015 | 5950 | 0.150 |
Why?
|
| Female | 9 | 2022 | 24018 | 0.150 |
Why?
|
| Cost-Benefit Analysis | 2 | 2022 | 176 | 0.150 |
Why?
|
| Middle Aged | 5 | 2023 | 11819 | 0.150 |
Why?
|
| Survival Analysis | 2 | 2018 | 362 | 0.150 |
Why?
|
| Male | 5 | 2023 | 22779 | 0.140 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2018 | 43 | 0.140 |
Why?
|
| Receptor, erbB-2 | 2 | 2018 | 149 | 0.130 |
Why?
|
| Adult | 4 | 2022 | 13458 | 0.120 |
Why?
|
| Hormones | 1 | 2015 | 56 | 0.110 |
Why?
|
| Proportional Hazards Models | 1 | 2015 | 512 | 0.110 |
Why?
|
| Sirolimus | 1 | 2014 | 70 | 0.110 |
Why?
|
| Receptors, Progesterone | 1 | 2014 | 90 | 0.110 |
Why?
|
| Retrospective Studies | 2 | 2022 | 2485 | 0.100 |
Why?
|
| Receptors, Estrogen | 1 | 2014 | 177 | 0.100 |
Why?
|
| Urban Population | 1 | 2015 | 364 | 0.100 |
Why?
|
| Medically Uninsured | 1 | 2013 | 64 | 0.100 |
Why?
|
| Logistic Models | 1 | 2015 | 1001 | 0.100 |
Why?
|
| Residence Characteristics | 1 | 2015 | 359 | 0.090 |
Why?
|
| Patient Compliance | 1 | 2013 | 225 | 0.090 |
Why?
|
| Socioeconomic Factors | 1 | 2015 | 1221 | 0.090 |
Why?
|
| Medicaid | 1 | 2013 | 138 | 0.090 |
Why?
|
| Body Mass Index | 1 | 2015 | 916 | 0.090 |
Why?
|
| Age Factors | 1 | 2013 | 1139 | 0.080 |
Why?
|
| Obesity | 1 | 2015 | 1131 | 0.060 |
Why?
|
| Cardiovascular Diseases | 1 | 2013 | 729 | 0.060 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2023 | 959 | 0.060 |
Why?
|
| Workers' Compensation | 1 | 2024 | 6 | 0.050 |
Why?
|
| State Government | 1 | 2024 | 21 | 0.050 |
Why?
|
| Mental Health Services | 1 | 2024 | 134 | 0.050 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2022 | 76 | 0.050 |
Why?
|
| Attitude to Health | 1 | 2023 | 336 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2022 | 358 | 0.040 |
Why?
|
| Focus Groups | 1 | 2021 | 398 | 0.040 |
Why?
|
| Medicare | 1 | 2022 | 326 | 0.040 |
Why?
|
| Public Health | 1 | 2022 | 405 | 0.030 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2016 | 23 | 0.030 |
Why?
|
| Propensity Score | 1 | 2016 | 58 | 0.030 |
Why?
|
| Hormone Replacement Therapy | 1 | 2016 | 49 | 0.030 |
Why?
|
| Minority Groups | 1 | 2022 | 663 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2016 | 174 | 0.030 |
Why?
|
| Vinblastine | 1 | 2015 | 9 | 0.030 |
Why?
|
| Michigan | 1 | 2015 | 52 | 0.030 |
Why?
|
| Drug Therapy | 1 | 2015 | 17 | 0.030 |
Why?
|
| Taxoids | 1 | 2015 | 50 | 0.030 |
Why?
|
| Neoplasm Staging | 1 | 2015 | 366 | 0.030 |
Why?
|
| Life Style | 1 | 2015 | 326 | 0.020 |
Why?
|
| Social Class | 1 | 2015 | 286 | 0.020 |
Why?
|
| Exercise | 1 | 2015 | 674 | 0.020 |
Why?
|